CIS: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in CIS

The CIS human and animal blood market dropped to $X in 2021, waning by -X% against the previous year. The total consumption indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2019 indices. As a result, consumption reached the peak level of $X, and then fell in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in CIS

In value terms, human and animal blood production dropped markedly to $X in 2021 estimated in export price. In general, production, however, saw a resilient expansion. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. As a result, production attained the peak level of $X, and then plummeted in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in CIS

In 2021, overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were finally on the rise to reach X tons for the first time since 2018, thus ending a two-year declining trend. Total exports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports decreased by -X% against 2018 indices. The volume of export peaked at X tons in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

In value terms, human and animal blood exports totaled $X in 2021. In general, exports recorded buoyant growth. The growth pace was the most rapid in 2016 with an increase of X%. The level of export peaked in 2021 and is expected to retain growth in years to come.

Exports by Country

Russia prevails in exports structure, amounting to X tons, which was approx. X% of total exports in 2021. The following exporters - Uzbekistan (X tons) and Belarus (X tons) - together made up X% of total exports.

From 2012 to 2021, average annual rates of growth with regard to human and animal blood exports from Russia stood at +X%. At the same time, Uzbekistan (+X%) and Belarus (+X%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing exporter exported in the CIS, with a CAGR of +X% from 2012-2021. While the share of Uzbekistan (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of Russia (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) remains the largest human and animal blood supplier in the CIS, comprising X% of total exports. The second position in the ranking was taken by Belarus ($X), with a X% share of total exports.

In Russia, human and animal blood exports expanded at an average annual rate of +X% over the period from 2012-2021. The remaining exporting countries recorded the following average annual rates of exports growth: Belarus (+X% per year) and Uzbekistan (-X% per year).

Export Prices by Country

The export price in the CIS stood at $X per ton in 2021, declining by -X% against the previous year. Export price indicated a pronounced increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood export price increased by +X% against 2015 indices. The most prominent rate of growth was recorded in 2020 an increase of X% against the previous year. As a result, the export price reached the peak level of $X per ton, and then dropped notably in the following year.

Prices varied noticeably by the country of origin: the country with the highest price was Belarus ($X per ton), while Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+X%), while the other leaders experienced a decline in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in CIS

In 2021, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by -X% to X tons, falling for the third consecutive year after three years of growth. Total imports indicated a measured expansion from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -X% against 2018 indices. The growth pace was the most rapid in 2016 with an increase of X% against the previous year. Over the period under review, imports attained the peak figure at X tons in 2018; however, from 2019 to 2021, imports remained at a lower figure.

In value terms, human and animal blood imports rose notably to $X in 2021. Overall, imports, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2017 when imports increased by X% against the previous year. The level of import peaked at $X in 2013; however, from 2014 to 2021, imports remained at a lower figure.

Imports by Country

Russia represented the key importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the CIS, with the volume of imports finishing at X tons, which was approx. X% of total imports in 2021. Belarus (X tons) held the second position in the ranking, followed by Kazakhstan (X tons). All these countries together held approx. X% share of total imports. Uzbekistan (X tons) and Azerbaijan (X tons) took a minor share of total imports.

Russia experienced a relatively flat trend pattern with regard to volume of imports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses. At the same time, Uzbekistan (+X%), Belarus (+X%), Kazakhstan (+X%) and Azerbaijan (+X%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing importer imported in the CIS, with a CAGR of +X% from 2012-2021. From 2012 to 2021, the share of Belarus, Kazakhstan and Uzbekistan increased by +X, +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the CIS, comprising X% of total imports. The second position in the ranking was taken by Belarus ($X), with a X% share of total imports. It was followed by Uzbekistan, with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of value in Russia stood at -X%. The remaining importing countries recorded the following average annual rates of imports growth: Belarus (+X% per year) and Uzbekistan (+X% per year).

Import Prices by Country

In 2021, the import price in the CIS amounted to $X per ton, increasing by X% against the previous year. Overall, the import price, however, saw a perceptible downturn. The pace of growth was the most pronounced in 2017 an increase of X%. Over the period under review, import prices attained the maximum at $X per ton in 2013; however, from 2014 to 2021, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Uzbekistan ($X per ton), while Kazakhstan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Uzbekistan (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :